Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.

Anglesio MS, Bashashati A, Wang YK, Senz J, Ha G, Yang W, Aniba MR, Prentice LM, Farahani H, Li Chang H, Karnezis AN, Marra MA, Yong PJ, Hirst M, Gilks B, Shah SP, Huntsman DG.

J Pathol. 2015 Jun;236(2):201-9. doi: 10.1002/path.4516. Epub 2015 Mar 23.

PMID:
25692284
2.

PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.

Yamamoto S, Tsuda H, Takano M, Iwaya K, Tamai S, Matsubara O.

J Pathol. 2011 Oct;225(2):189-94. doi: 10.1002/path.2940. Epub 2011 Jul 7.

PMID:
21735444
3.

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O.

Mod Pathol. 2012 Apr;25(4):615-24. doi: 10.1038/modpathol.2011.189. Epub 2011 Dec 9.

4.

Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.

Er TK, Su YF, Wu CC, Chen CC, Wang J, Hsieh TH, Herreros-Villanueva M, Chen WT, Chen YT, Liu TC, Chen HS, Tsai EM.

J Mol Med (Berl). 2016 Jul;94(7):835-47. doi: 10.1007/s00109-016-1395-2. Epub 2016 Feb 27.

PMID:
26920370
5.

ARID1A mutations in endometriosis-associated ovarian carcinomas.

Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih IeM, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG.

N Engl J Med. 2010 Oct 14;363(16):1532-43. doi: 10.1056/NEJMoa1008433. Epub 2010 Sep 8.

6.

Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.

Xiao W, Awadallah A, Xin W.

Int J Clin Exp Pathol. 2012;5(7):642-50. Epub 2012 Sep 5.

7.

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.

Wiegand KC, Hennessy BT, Leung S, Wang Y, Ju Z, McGahren M, Kalloger SE, Finlayson S, Stemke-Hale K, Lu Y, Zhang F, Anglesio MS, Gilks B, Mills GB, Huntsman DG, Carey MS.

BMC Cancer. 2014 Feb 22;14:120. doi: 10.1186/1471-2407-14-120.

8.

The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.

Chene G, Ouellet V, Rahimi K, Barres V, Provencher D, Mes-Masson AM.

Int J Gynaecol Obstet. 2015 Jul;130(1):27-30. doi: 10.1016/j.ijgo.2015.02.021. Epub 2015 Apr 11.

PMID:
25912412
9.

The role of p53 mutation in the carcinomas arising from endometriosis.

Akahane T, Sekizawa A, Purwosunu Y, Nagatsuka M, Okai T.

Int J Gynecol Pathol. 2007 Jul;26(3):345-51.

PMID:
17581423
10.

Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.

Matsumoto T, Yamazaki M, Takahashi H, Kajita S, Suzuki E, Tsuruta T, Saegusa M.

Am J Clin Pathol. 2015 Sep;144(3):452-63. doi: 10.1309/AJCPZ5T2POOFMQVN.

PMID:
26276776
11.

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.

Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O.

Virchows Arch. 2012 Jan;460(1):77-87. doi: 10.1007/s00428-011-1169-8. Epub 2011 Nov 26.

PMID:
22120431
12.

Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?

Gounaris I, Charnock-Jones DS, Brenton JD.

J Pathol. 2011 Oct;225(2):157-60. doi: 10.1002/path.2970.

PMID:
21898874
13.

Common genetic changes between endometriosis and ovarian cancer.

Obata K, Hoshiai H.

Gynecol Obstet Invest. 2000;50 Suppl 1:39-43. Review.

PMID:
11093060
14.

The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.

Munksgaard PS, Blaakaer J.

Gynecol Oncol. 2012 Jan;124(1):164-9. doi: 10.1016/j.ygyno.2011.10.001. Epub 2011 Oct 26. Review.

PMID:
22032835
15.

[Preneoplasias of ovarian carcinoma: biological and clinical aspects of different pathways of tumorigenesis].

Staebler A.

Pathologe. 2011 Nov;32 Suppl 2:265-70. doi: 10.1007/s00292-011-1488-1. Review. German.

PMID:
21809064
16.

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IeM, Wang TL.

J Pathol. 2014 Mar;232(4):473-81. doi: 10.1002/path.4315.

17.

Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.

Sekizawa A, Amemiya S, Otsuka J, Saito H, Farina A, Okai T, Tachikawa T.

Med Electron Microsc. 2004 Jun;37(2):97-100. Review.

PMID:
15221651
18.

Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.

Gadducci A, Lanfredini N, Tana R.

Gynecol Endocrinol. 2014 Sep;30(9):612-7. doi: 10.3109/09513590.2014.926325. Epub 2014 Jun 6. Review.

PMID:
24905724
19.

Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.

Xu B, Hamada S, Kusuki I, Itoh R, Kitawaki J.

Gynecol Oncol. 2011 Feb;120(2):239-46. doi: 10.1016/j.ygyno.2010.10.036. Epub 2010 Dec 3.

PMID:
21130491
20.

Cancer-Associated Mutations in Endometriosis without Cancer.

Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noë M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, Ho J, Wu RC, Lac V, Ogawa H, Tessier-Cloutier B, Alhassan R, Wang A, Wang Y, Cohen JD, Wong F, Hasanovic A, Orr N, Zhang M, Popoli M, McMahon W, Wood LD, Mattox A, Allaire C, Segars J, Williams C, Tomasetti C, Boyd N, Kinzler KW, Gilks CB, Diaz L, Wang TL, Vogelstein B, Yong PJ, Huntsman DG, Shih IM.

N Engl J Med. 2017 May 11;376(19):1835-1848. doi: 10.1056/NEJMoa1614814.

Supplemental Content

Support Center